These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21061232)

  • 1. Homogenous asymmetric hydrogenation: Recent trends and industrial applications.
    Palmer AM; Zanotti-Gerosa A
    Curr Opin Drug Discov Devel; 2010; 13(6):698-716. PubMed ID: 21061232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examples of catalytic asymmetric amine synthesis using organic catalysts.
    Rios R; Córdova A
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):824-47. PubMed ID: 19894193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a chiral toolbox for asymmetric catalytic reactions.
    Zhang X
    Enantiomer; 1999; 4(6):541-55. PubMed ID: 10672459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industrial-scale synthesis and applications of asymmetric hydrogenation catalysts.
    Johnson NB; Lennon IC; Moran PH; Ramsden JA
    Acc Chem Res; 2007 Dec; 40(12):1291-9. PubMed ID: 17803270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in hydrogenation technology for fine-chemical and pharmaceutical applications.
    Machado RM; Heier KR; Broekhuis RR
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):745-55. PubMed ID: 11899614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broader, greener, and more efficient: recent advances in asymmetric transfer hydrogenation.
    Wang C; Wu X; Xiao J
    Chem Asian J; 2008 Oct; 3(10):1750-70. PubMed ID: 18752225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric transfer hydrogenation of ketones with bifunctional transition metal-based molecular catalysts.
    Ikariya T; Blacker AJ
    Acc Chem Res; 2007 Dec; 40(12):1300-8. PubMed ID: 17960897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous-phase asymmetric transfer hydrogenation of ketones--a greener approach to chiral alcohols.
    Wu X; Xiao J
    Chem Commun (Camb); 2007 Jun; (24):2449-66. PubMed ID: 17563797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of binary component ligands in chiral catalyst library engineering for enantioselective reactions.
    Ding K
    Chem Commun (Camb); 2008 Feb; (8):909-21. PubMed ID: 18283341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inventing and understanding catalytic, enantioselective reactions.
    Shibasaki M; Kumagai N; Mashiko T
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):862-75. PubMed ID: 19894195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of chiral building blocks for use in drug discovery.
    Marino ST; Stachurska-Buczek D; Huggins DA; Krywult BM; Sheehan CS; Nguyen T; Choi N; Parsons JG; Griffiths PG; James IW; Bray AM; White JM; Boyce RS
    Molecules; 2004 May; 9(6):405-26. PubMed ID: 18007441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industrial Ziegler-type hydrogenation catalysts made from Co(neodecanoate)2 or Ni(2-ethylhexanoate)2 and AlEt3: evidence for nanoclusters and sub-nanocluster or larger Ziegler-nanocluster based catalysis.
    Alley WM; Hamdemir IK; Wang Q; Frenkel AI; Li L; Yang JC; Menard LD; Nuzzo RG; Özkar S; Yih KH; Johnson KA; Finke RG
    Langmuir; 2011 May; 27(10):6279-94. PubMed ID: 21480617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-supported chiral catalysts for heterogeneous enantioselective reactions.
    Ding K; Wang Z; Wang X; Liang Y; Wang X
    Chemistry; 2006 Jul; 12(20):5188-97. PubMed ID: 16568490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid bidentate phosphorus ligands in asymmetric catalysis: privileged ligand approach vs. combinatorial strategies.
    Wassenaar J; Reek JN
    Org Biomol Chem; 2011 Mar; 9(6):1704-13. PubMed ID: 21283872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in transition metal-catalyzed enantioselective hydrogenation of unprotected enamines.
    Xie JH; Zhu SF; Zhou QL
    Chem Soc Rev; 2012 Jun; 41(11):4126-39. PubMed ID: 22509499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric hydrogenation of unsaturated ureas with the BIPI ligands.
    Busacca CA; Lorenz JC; Grinberg N; Haddad N; Lee H; Li Z; Liang M; Reeves D; Saha A; Varsolona R; Senanayake CH
    Org Lett; 2008 Jan; 10(2):341-4. PubMed ID: 18095698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric catalytic hydrogenation. Design of new Ru catalysts and chiral ligands: from laboratory to industrial applications.
    Genet JP
    Acc Chem Res; 2003 Dec; 36(12):908-18. PubMed ID: 14674782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spiro skeletons: a class of privileged structure for chiral ligand design.
    Ding K; Han Z; Wang Z
    Chem Asian J; 2009 Jan; 4(1):32-41. PubMed ID: 18770872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric hydrogenation of prochiral amino ketones to amino alcohols for pharmaceutical use.
    Klingler FD
    Acc Chem Res; 2007 Dec; 40(12):1367-76. PubMed ID: 18052332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric transfer hydrogenation of imines catalyzed by a polymer-immobilized chiral catalyst.
    Haraguchi N; Tsuru K; Arakawa Y; Itsuno S
    Org Biomol Chem; 2009 Jan; 7(1):69-75. PubMed ID: 19081948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.